Related Experiment Video
Updated: Jul 5, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
In vitro susceptibility of the Streptococcus milleri group to antimicrobial peptides
K L Bartie1, D A Devine, M J Wilson
1Department of Oral Microbiology, Leeds Dental Institute, Clarendon Way, University of Leeds, Leeds, UK.
Aim:
To determine the susceptibility of strains of the Streptococcus milleri group (SMG) to commercially available antimicrobial peptides.
Methodology:
Thirty strains of SMG from a range of sources were assessed for their susceptibility to 10 antimicrobial peptides of either human, animal or insect origin, using a double layer diffusion assay.
Results:
The majority of the test strains were sensitive to the amidated peptides, mastoparan (100%; n = 30), magainin 2 amide (95%; n = 21) and indolicin (91%; n = 23). Some strains were susceptible to cecropin B (30%; n = 30) and histatin (10%; n = 30), whilst no activity was observed for the defensins HNP-1 and HNP-2, histatin 8, cecropin P1 and magainin 2.
Conclusions:
The majority of strains were resistant to the human derived peptides. The ability to resist such peptides may be a factor in the colonisation of the oral cavity and the survival and initiation of infection in the pulp and root canal environment. Interestingly, the present study indicated that amidated and alpha helical peptides exhibit antimicrobial activity against SMG. Structural modification of these peptides may allow a targeted approach for the development of these substances as preventative or therapeutic agents.
Insights
The Streptococcus milleri group (SMG) showed sensitivity to amidated antimicrobial peptides like mastoparan and magainin 2 amide. Resistance to human-derived peptides may aid oral cavity colonization and infection survival.
Area of Science:
- Microbiology
- Biochemistry
- Infectious Diseases
Background:
- The Streptococcus milleri group (SMG) comprises bacteria frequently associated with various infections.
- Understanding their susceptibility to antimicrobial agents is crucial for effective treatment strategies.
Purpose of the Study:
- To evaluate the susceptibility of Streptococcus milleri group strains to a panel of commercially available antimicrobial peptides.
- To identify specific antimicrobial peptides with activity against SMG.
Main Methods:
- Thirty strains of the Streptococcus milleri group were tested.
- Susceptibility was assessed using a double-layer diffusion assay against ten antimicrobial peptides of human, animal, or insect origin.
Main Results:
- Most SMG strains were sensitive to amidated peptides: mastoparan (100%), magainin 2 amide (95%), and indolicin (91%).
- Cecropin B and histatin showed lower activity, while defensins (HNP-1, HNP-2), histatin 8, cecropin P1, and magainin 2 were inactive.
- A majority of strains were resistant to human-derived peptides.
Conclusions:
- Amidated and alpha-helical antimicrobial peptides demonstrate activity against the Streptococcus milleri group.
- Resistance to human peptides might contribute to SMG's colonization and survival in oral and endodontic infections.
- Structural modifications of active peptides could lead to novel preventative or therapeutic agents.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
